down arrow

Amanta Healthcar

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
103.24
1.42 (1.39%)
BSENSE

Dec 05

BSE+NSE Vol: 1.0 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Amanta Healthcare Ltd stock-summary
stock-summary
Amanta Healthcare Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Amanta Healthcare Limited was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership Firm "Marck Parenterals (India)" on January 06, 1995. The Company name was changed to "Marck Biosciences Limited" vide a fresh Certificate of Incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005 and was again changed to "Amanta Healthcare Limited" dated June 24, 2014.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (2.46%)

FIIs

Held by 9 FIIs (2.21%)

Promoter with highest holding

Bhavesh Girishbhai Patel (16.1%)

Highest Public shareholder

Bandhan Small Cap Fund (2.46%)

Individual Investors Holdings

20.28%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
71 Cr
(Quarterly Results - Sep 2025)
Net Profit:
1 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 393 Cr (Micro Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.40

stock-summary
Return on Equity

4.98%

stock-summary
Price to Book

1.88

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."